ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Corona Remedies Ltd

NSE: CORONA · BSE: 544644 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹2,387.30
Market cap: ₹14,601 Cr
Revenue (annual): ₹1,403 Cr
Net profit (annual): ₹185.1 Cr
P/E (TTM): 70.5×Sector 43.8×
Promoter holding: 69.00%+0.00% QoQ
FII holding: 4.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

30 Oct 2026 18:28 IST BSE

Financial Results

Corona Remedies Q2 FY27 Results: Net Profit ₹60.3 Cr, Up 15.3% YoY

Corona Remedies Ltd reported revenue from operations of ₹441.2 Cr (+22.2% YoY) and net profit of ₹60.3 Cr (+15.3% YoY) for Q2 FY27.

Key figure: Net profit ₹60.3 Cr · +15.3% YoY

Open full results → Read the filing ↗

31 Jul 2026 17:20 IST BSE

Financial Results

Corona Remedies Q1 FY27 Results: Net Profit ₹60.1 Cr, Up 30.1% YoY

Corona Remedies Ltd reported revenue from operations of ₹422.4 Cr (+21.9% YoY) and net profit of ₹60.1 Cr (+30.1% YoY) for Q1 FY27.

Key figure: Net profit ₹60.1 Cr · +30.1% YoY

Open full results → Read the filing ↗

11 May 2026 18:52 IST NSE

Financial Results

Corona Remedies Q4 FY26 Results: Net Profit ₹45.3 Cr, Up 43.4% YoY

Corona Remedies Ltd reported revenue from operations of ₹353.1 Cr (+20.2% YoY) and net profit of ₹45.3 Cr (+43.4% YoY) for Q4 FY26.

Key figure: Net profit ₹45.3 Cr · +43.4% YoY

Open full results → Read the filing ↗

11 May 2026 18:33 IST NSE

Financial Results

Corona Remedies Financial Results

CORONA Remedies reported FY26 total standalone income of ₹1,413.83 Crore. The Board recommended a 100% final dividend of ₹10 per equity share.

Value: ₹1,414 Cr

Open announcement → Read the filing ↗

Corona Remedies Ltd by type